LOH events involving the ATM locus and ATM protein deficiency occur in 14% and 34%, respectively, of patients with chronic lymphocytic leukemia (CLL) and have been found to correlate with aggressive disease and worse outcome [45]. The gene discussed is ATM; the disease is B-cell chronic lymphocytic leukemia.